Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: +$1.9M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 10 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 11 most recent Form 4 transactions.
| May 1 | VRTX | Vertex Pharmaceuticals… | AGRANT◆ | 2,866 | — | — | — | Open the original filing on SEC.gov |
| Apr 15 | VRTX | Vertex Pharmaceuticals… | AGRANT◆ | 107.35 | $442.50 | $47.5K | — | Open the original filing on SEC.gov |
| Jan 15 | VRTX | Vertex Pharmaceuticals… | AGRANT◆ | 107.09 | $443.56 | $47.5K | — | Open the original filing on SEC.gov |
| Oct 15, 2025 | VRTX | Vertex Pharmaceuticals… | AGRANT◆ | 115.77 | $410.31 | $47.5K | — | Open the original filing on SEC.gov |
| Aug 6, 2025 | VRTX | Vertex Pharmaceuticals… | PBUY | 3,366 | $389.84 | $1.3M | +8.1% | Open the original filing on SEC.gov |
| Aug 6, 2025 | VRTX | Vertex Pharmaceuticals… | PBUY | 1,634 | $389.36 | $636.2K | +4.1% | Open the original filing on SEC.gov |
| Jul 15, 2025 | VRTX | Vertex Pharmaceuticals… | AGRANT◆ | 101.21 | $469.34 | $47.5K | — | Open the original filing on SEC.gov |
| May 1, 2025 | VRTX | Vertex Pharmaceuticals… | AGRANT◆ | 2,398 | — | — | — | Open the original filing on SEC.gov |
| Apr 15, 2025 | VRTX | Vertex Pharmaceuticals… | AGRANT◆ | 95.48 | $497.51 | $47.5K | — | Open the original filing on SEC.gov |